tuned for more details on the program, keynote speakers, and registration opening. Mark in your calendar and get ready to join experts, innovators, and thought leaders in Interventional Pulmonology from around the world.
taking place on November 26–27, 2026, in Barcelona, Spain as a HYBRID EVENT—offering participants the flexibility to join in person or virtually from anywhere across the globe. 3rd Global Summit on Heart and Cardiovascular Care” (Heart Congress...
Vietnam Medical Devices Association highly appreciates Vietnam Advertisement and Fair Exhibition Joint Stock Company (VIETFAIR) organizing The international exhibition on Pharmaceutical Manufacturing Technology - VietPharmaTech 2026 / The...
on venture formation and scaling, to senior advisory roles with major pharmaceutical companies. “It’s a great honor to join the Board of Directors at Bruker Corporation, a company at the forefront of AI-accelerated, deep functional proteomics,...
Investigator of the OCEANIC-STROKE clinical study and Senior Scientist at Population Health Research Institute (PHRI), a joint institute of Hamilton Health Sciences and McMaster University (Ontario, Canada). “I believe SUNHARBO introduces an...
on the study's previously reported Week 16 results, which demonstrated statistically significant superiority in ACR50 joint outcomes versus risankizumab at Week 16 in psoriatic arthritis (PsA). Numerically greater rates of ACR50 were sustained...
(ACR) Convergence 2026. Psoriatic arthritis is a chronic, immune-mediated inflammatory disease that can affect both the joints and skin.3,4 Nearly 30 percent of people with plaque psoriasis also develop psoriatic arthritis.5,6 It can cause pain,...
Stevanato Group’s expertise in prefillable high-value syringe systems, primary containment and system performance. The joint work evaluates Stevanato Group’s EZ-fill® Nexa® and Alba® glass syringe platforms together with Aptar Pharma PremiumCoat®...
Generating antibodies that activate these receptors has been a longstanding goal in antibody discovery. Pythia-1 reasons jointly over amino acid sequence, three-dimensional atomic structure and explicit design specifications. The platform provides...
Generating antibodies that activate these receptors has been a longstanding goal in antibody discovery. Pythia-1 reasons jointly over amino acid sequence, three-dimensional atomic structure and explicit design specifications. The platform provides...
stated, “The partnership between PULMOTREE and Aptar Pharma has been built on close, trust-based collaboration, and joining Aptar is the natural next step on that shared path. For our customers and partners, this acquisition is intended to provide...
dispensing, today announced the appointment of Virginie Maes as President of Aptar Pharma, effective January 1, 2027. Maes joins Aptar from Amcor, where she currently leads its global Flexibles Pharma and Medical packaging business, spanning North...
under the international guidance have been approved by the U.S. Food and Drug Administration (FDA) alone. Developed jointly with GEA, the ConsiGma® CDC Flex platform also incorporates SimpleCT, a suite of automation and control tools with smart...
CaseBioscience® announced its participation in a multidisciplinary team led by Likarda that has been awarded up to $7.3 million by the Advanced Research Projects Agency for Health (ARPA-H) through its BioStabilization Systems (BoSS) program. Led...
application, go-bag optimization and a smaller footprint for tactical, prehospital and hospital use. The new form factor joins the original TRAUMAGEL, which will remain fully available and supported in the field. TRAUMAGEL is a plant-based...
TCR-based cancer immunotherapies, today announced the appointment of Peter Olagunju as Chief Executive Officer. Olagunju joins ImmunoScape as the company prepares to advance its Seed and Boost platform into the clinic. Co-founder Michael Fehlings,...
initiatives within their organizations. Mike will play a leading role in helping us make that transition.” “I’m excited to join the company to help power this scientific and strategic pivot. Late-stage labs are becoming increasingly automated:...
to the convenience of ready-to-feed formula at pricing similar to powder. Similac 360 Total Care Made With Whole Milk joins Abbott's extensive portfolio of infant formulas and expands feeding options for families seeking a formula made with whole...
and former president of DePuy Synthes U.S. and most recently president of U.S. Surgical and Global R&D at Enovis, has joined the Peptilogics board of directors. His background in leading large orthopedic device businesses, including successful...
to train better models, increase success rates, and accelerate discovery. Atinary and Chemspeed have established a joint demonstration laboratory at Chemspeed’s headquarters near Basel, Switzerland. Atinary’s Self-Driving Lab in Boston opened in...